{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:25:17Z","timestamp":1791325517879,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3603,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/modpathol.2012.164","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T06:26:16Z","timestamp":1349936776000},"page":"448-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Sabina","family":"Davidsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Ohlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swen-Olof","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Meisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelangelo","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ove","family":"Andr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2012.164_bib1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0959-8049(96)00492-3","article-title":"Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990","volume":"33","author":"Black","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2012.164_bib2","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/modpathol.2012.164_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000386035","article-title":"The concept of immunological surveillance","volume":"13","author":"Burnet","year":"1970","journal-title":"Prog Exp Tumor Res"},{"key":"10.1038\/modpathol.2012.164_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<607::AID-IJC17>3.0.CO;2-X","article-title":"Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes","volume":"81","author":"Nguyen","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2012.164_bib5","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.4049\/jimmunol.168.11.5954","article-title":"Characterization of CD4(+) CTLs ex vivo","volume":"168","author":"Appay","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/modpathol.2012.164_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1189\/jlb.70.2.171","article-title":"Leukocyte recruitment at sites of tumor: dissonant orchestration","volume":"70","author":"Carlos","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1038\/modpathol.2012.164_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00000478-199210000-00008","article-title":"Incidental lymphocytic prostatitis. Selective involvement with nonmalignant glands","volume":"16","author":"Blumenfeld","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2012.164_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/modpathol.2012.164_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2005.06.001","article-title":"EAU guidelines on prostate cancer","volume":"48","author":"Aus","year":"2005","journal-title":"Eur Urol"},{"key":"10.1038\/modpathol.2012.164_bib10","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","article-title":"Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis","volume":"155","author":"De Marzo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2012.164_bib11","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/0959-8049(94)E0159-2","article-title":"Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma","volume":"30A","author":"Vesalainen","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2012.164_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0090-4295(99)00152-1","article-title":"High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist Multi Center Study Group","volume":"54","author":"Irani","year":"1999","journal-title":"Urology"},{"key":"10.1038\/modpathol.2012.164_bib13","first-page":"4435","article-title":"Tumour-infiltrating lymphocytes: a prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy","volume":"25","author":"Karja","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1038\/modpathol.2012.164_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bjc.6601943","article-title":"The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer","volume":"91","author":"McArdle","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1038\/modpathol.2012.164_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pros.20538","article-title":"The number of regulatory T cells in prostate cancer is associated with the androgen receptor and hypoxia-inducible factor (HIF)-2alpha but not HIF-1alpha","volume":"67","author":"Fox","year":"2007","journal-title":"Prostate"},{"key":"10.1038\/modpathol.2012.164_bib16","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1158\/1078-0432.CCR-07-0842","article-title":"CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer","volume":"13","author":"Kiniwa","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2012.164_bib17","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.4049\/jimmunol.177.10.7398","article-title":"CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients","volume":"177","author":"Miller","year":"2006","journal-title":"J Immunol"},{"key":"10.1038\/modpathol.2012.164_bib18","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s00262-005-0092-8","article-title":"CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers","volume":"55","author":"Kono","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1038\/modpathol.2012.164_bib19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1038\/modpathol.2012.164_bib20","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0022-5347(05)00734-2","article-title":"How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden","volume":"17","author":"Andren","year":"2006","journal-title":"J Urol"},{"key":"10.1038\/modpathol.2012.164_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.20855","article-title":"Survival in prostate carcinoma\u2014outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of Sweden","volume":"103","author":"Aus","year":"2005","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2012.164_bib22","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1001\/jama.291.22.2713","article-title":"Natural history of early, localized prostate cancer","volume":"291","author":"Johansson","year":"2004","journal-title":"JAMA"},{"key":"10.1038\/modpathol.2012.164_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.eururo.2010.04.028","article-title":"Original Gleason system versus 2005 ISUP modified Gleason system: the importance of indicating which system is used in the patient\u2019s pathology and clinical reports","volume":"58","author":"Montironi","year":"2010","journal-title":"Eur Urol"},{"key":"10.1038\/modpathol.2012.164_bib24","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1158\/1055-9965.EPI-11-0373","article-title":"Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer","volume":"20","author":"Davidsson","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1038\/modpathol.2012.164_bib25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood-2005-02-0607","article-title":"CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients","volume":"106","author":"Nishikawa","year":"2005","journal-title":"Blood"},{"key":"10.1038\/modpathol.2012.164_bib26","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-07-5164","article-title":"Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing","volume":"14","author":"Sfanos","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2012.164_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1158\/1078-0432.CCR-07-2056","article-title":"Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer","volume":"14","author":"Yokokawa","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2012.164_bib28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00508-011-0096-7","article-title":"Comparative study of frequency of different lymphocytes subpopulation in peripheral blood of patients with prostate cancer and benign prostatic hyperplasia","volume":"123","author":"Sotosek","year":"2011","journal-title":"Wien Klin Wochenschr"},{"key":"10.1038\/modpathol.2012.164_bib29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2012.164_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/(SICI)1097-0045(19970401)31:1<61::AID-PROS10>3.0.CO;2-M","article-title":"TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity","volume":"31","author":"Barrack","year":"1997","journal-title":"Prostate"},{"key":"10.1038\/modpathol.2012.164_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10555-006-9006-2","article-title":"Transforming growth factor-beta in cancer and metastasis","volume":"25","author":"Jakowlew","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1038\/modpathol.2012.164_bib32","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/eji.200526189","article-title":"Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level","volume":"35","author":"Roncador","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1038\/modpathol.2012.164_bib33","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1158\/0008-5472.CAN-07-5664","article-title":"The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells","volume":"68","author":"Ebert","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2012.164_bib34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0463.2010.02604.x","article-title":"Distribution of Foxp3-, CD4- and CD8-positive lymphocytic cells in benign and malignant prostate tissue","volume":"118","author":"Valdman","year":"2010","journal-title":"APMIS"},{"key":"10.1038\/modpathol.2012.164_bib35","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/01.ju.0000158161.15277.78","article-title":"Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution?","volume":"173","author":"Cohen","year":"2005","journal-title":"J Urol"},{"key":"10.1038\/modpathol.2012.164_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijmm.2010.08.014","article-title":"Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells","volume":"301","author":"Fassi Fehri","year":"2010","journal-title":"Int J Med Microbiol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012164","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222034457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222034457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2012164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:10:34Z","timestamp":1760231434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222034457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0893395222034457"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2012.164","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2012.164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}